Pre-order Enquiry
Request Free Sample
Global Pharyngeal Cancer Therapeutics Market 2019 by Company, Regions, Type and Application, Forecast to 2024
SKU ID : GIR-14966858 | Publishing Date : 06-Dec-2019 | No. of pages : 105
Request Sample
Request Customization
Check DiscountsDetailed TOC of Global Pharyngeal Cancer Therapeutics Market 2019 by Company, Regions, Type and Application, Forecast to 2024
Table of Contents1 Pharyngeal Cancer Therapeutics Market Overview
1.1 Product Overview and Scope of Pharyngeal Cancer Therapeutics
1.2 Classification of Pharyngeal Cancer Therapeutics by Types
1.2.1 Global Pharyngeal Cancer Therapeutics Revenue Comparison by Types (2019-2024)
1.2.2 Global Pharyngeal Cancer Therapeutics Revenue Market Share by Types in 2018
1.2.3 Targeted Therapy
1.2.4 Chemotherapy
1.3 Global Pharyngeal Cancer Therapeutics Market by Application
1.3.1 Global Pharyngeal Cancer Therapeutics Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Pharyngeal Cancer Therapeutics Market by Regions
1.4.1 Global Pharyngeal Cancer Therapeutics Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Pharyngeal Cancer Therapeutics Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Pharyngeal Cancer Therapeutics Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Pharyngeal Cancer Therapeutics Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Pharyngeal Cancer Therapeutics Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Pharyngeal Cancer Therapeutics Status and Prospect (2014-2024)
1.5 Global Market Size of Pharyngeal Cancer Therapeutics (2014-2024)
2 Company Profiles
2.1 AstraZeneca Plc
2.1.1 Business Overview
2.1.2 Pharyngeal Cancer Therapeutics Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 AstraZeneca Plc Pharyngeal Cancer Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
2.2 Sanofi
2.2.1 Business Overview
2.2.2 Pharyngeal Cancer Therapeutics Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Sanofi Pharyngeal Cancer Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
2.3 F. Hoffmann-La Roche Ltd.
2.3.1 Business Overview
2.3.2 Pharyngeal Cancer Therapeutics Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 F. Hoffmann-La Roche Ltd. Pharyngeal Cancer Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
2.4 Bristol-Myers Squibb Co.
2.4.1 Business Overview
2.4.2 Pharyngeal Cancer Therapeutics Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Bristol-Myers Squibb Co. Pharyngeal Cancer Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
2.5 Pfizer Inc.
2.5.1 Business Overview
2.5.2 Pharyngeal Cancer Therapeutics Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Pfizer Inc. Pharyngeal Cancer Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
2.6 Eli Lilly and Co.
2.6.1 Business Overview
2.6.2 Pharyngeal Cancer Therapeutics Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Eli Lilly and Co. Pharyngeal Cancer Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
2.7 Teva Pharmaceutical Industries Ltd.
2.7.1 Business Overview
2.7.2 Pharyngeal Cancer Therapeutics Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Teva Pharmaceutical Industries Ltd. Pharyngeal Cancer Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
2.8 Mylan NV
2.8.1 Business Overview
2.8.2 Pharyngeal Cancer Therapeutics Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Mylan NV Pharyngeal Cancer Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
2.9 Merck & Co., Inc.
2.9.1 Business Overview
2.9.2 Pharyngeal Cancer Therapeutics Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Merck & Co., Inc. Pharyngeal Cancer Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
2.10 Sun Pharmaceutical Industries Ltd.
2.10.1 Business Overview
2.10.2 Pharyngeal Cancer Therapeutics Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Sun Pharmaceutical Industries Ltd. Pharyngeal Cancer Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
3 Global Pharyngeal Cancer Therapeutics Market Competition, by Players
3.1 Global Pharyngeal Cancer Therapeutics Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Pharyngeal Cancer Therapeutics Players Market Share
3.2.2 Top 10 Pharyngeal Cancer Therapeutics Players Market Share
3.3 Market Competition Trend
4 Global Pharyngeal Cancer Therapeutics Market Size by Regions
4.1 Global Pharyngeal Cancer Therapeutics Revenue and Market Share by Regions
4.2 North America Pharyngeal Cancer Therapeutics Revenue and Growth Rate (2014-2019)
4.3 Europe Pharyngeal Cancer Therapeutics Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Pharyngeal Cancer Therapeutics Revenue and Growth Rate (2014-2019)
4.5 South America Pharyngeal Cancer Therapeutics Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Pharyngeal Cancer Therapeutics Revenue and Growth Rate (2014-2019)
5 North America Pharyngeal Cancer Therapeutics Revenue by Countries
5.1 North America Pharyngeal Cancer Therapeutics Revenue by Countries (2014-2019)
5.2 USA Pharyngeal Cancer Therapeutics Revenue and Growth Rate (2014-2019)
5.3 Canada Pharyngeal Cancer Therapeutics Revenue and Growth Rate (2014-2019)
5.4 Mexico Pharyngeal Cancer Therapeutics Revenue and Growth Rate (2014-2019)
6 Europe Pharyngeal Cancer Therapeutics Revenue by Countries
6.1 Europe Pharyngeal Cancer Therapeutics Revenue by Countries (2014-2019)
6.2 Germany Pharyngeal Cancer Therapeutics Revenue and Growth Rate (2014-2019)
6.3 UK Pharyngeal Cancer Therapeutics Revenue and Growth Rate (2014-2019)
6.4 France Pharyngeal Cancer Therapeutics Revenue and Growth Rate (2014-2019)
6.5 Russia Pharyngeal Cancer Therapeutics Revenue and Growth Rate (2014-2019)
6.6 Italy Pharyngeal Cancer Therapeutics Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Pharyngeal Cancer Therapeutics Revenue by Countries
7.1 Asia-Pacific Pharyngeal Cancer Therapeutics Revenue by Countries (2014-2019)
7.2 China Pharyngeal Cancer Therapeutics Revenue and Growth Rate (2014-2019)
7.3 Japan Pharyngeal Cancer Therapeutics Revenue and Growth Rate (2014-2019)
7.4 Korea Pharyngeal Cancer Therapeutics Revenue and Growth Rate (2014-2019)
7.5 India Pharyngeal Cancer Therapeutics Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Pharyngeal Cancer Therapeutics Revenue and Growth Rate (2014-2019)
8 South America Pharyngeal Cancer Therapeutics Revenue by Countries
8.1 South America Pharyngeal Cancer Therapeutics Revenue by Countries (2014-2019)
8.2 Brazil Pharyngeal Cancer Therapeutics Revenue and Growth Rate (2014-2019)
8.3 Argentina Pharyngeal Cancer Therapeutics Revenue and Growth Rate (2014-2019)
8.4 Colombia Pharyngeal Cancer Therapeutics Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Pharyngeal Cancer Therapeutics by Countries
9.1 Middle East and Africa Pharyngeal Cancer Therapeutics Revenue by Countries (2014-2019)
9.2 Saudi Arabia Pharyngeal Cancer Therapeutics Revenue and Growth Rate (2014-2019)
9.3 UAE Pharyngeal Cancer Therapeutics Revenue and Growth Rate (2014-2019)
9.4 Egypt Pharyngeal Cancer Therapeutics Revenue and Growth Rate (2014-2019)
9.5 Nigeria Pharyngeal Cancer Therapeutics Revenue and Growth Rate (2014-2019)
9.6 South Africa Pharyngeal Cancer Therapeutics Revenue and Growth Rate (2014-2019)
10 Global Pharyngeal Cancer Therapeutics Market Segment by Type
10.1 Global Pharyngeal Cancer Therapeutics Revenue and Market Share by Type (2014-2019)
10.2 Global Pharyngeal Cancer Therapeutics Market Forecast by Type (2019-2024)
10.3 Targeted Therapy Revenue Growth Rate (2014-2024)
10.4 Chemotherapy Revenue Growth Rate (2014-2024)
11 Global Pharyngeal Cancer Therapeutics Market Segment by Application
11.1 Global Pharyngeal Cancer Therapeutics Revenue Market Share by Application (2014-2019)
11.2 Pharyngeal Cancer Therapeutics Market Forecast by Application (2019-2024)
11.3 Hospital Revenue Growth (2014-2019)
11.4 Clinic Revenue Growth (2014-2019)
11.5 Other Revenue Growth (2014-2019)
12 Global Pharyngeal Cancer Therapeutics Market Size Forecast (2019-2024)
12.1 Global Pharyngeal Cancer Therapeutics Market Size Forecast (2019-2024)
12.2 Global Pharyngeal Cancer Therapeutics Market Forecast by Regions (2019-2024)
12.3 North America Pharyngeal Cancer Therapeutics Revenue Market Forecast (2019-2024)
12.4 Europe Pharyngeal Cancer Therapeutics Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Pharyngeal Cancer Therapeutics Revenue Market Forecast (2019-2024)
12.6 South America Pharyngeal Cancer Therapeutics Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Pharyngeal Cancer Therapeutics Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Figures, Tables and Charts Available in Global Pharyngeal Cancer Therapeutics Market 2019 by Company, Regions, Type and Application, Forecast to 2024
List of Tables and FiguresFigure Pharyngeal Cancer Therapeutics Picture
Table Product Specifications of Pharyngeal Cancer Therapeutics
Table Global Pharyngeal Cancer Therapeutics and Revenue (Million USD) Market Split by Product Type
Figure Global Pharyngeal Cancer Therapeutics Revenue Market Share by Types in 2018
Figure Targeted Therapy Picture
Figure Chemotherapy Picture
Table Global Pharyngeal Cancer Therapeutics Revenue (Million USD) by Application (2014-2024)
Figure Pharyngeal Cancer Therapeutics Revenue Market Share by Applications in 2018
Figure Hospital Picture
Figure Clinic Picture
Figure Other Picture
Table Global Market Pharyngeal Cancer Therapeutics Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Pharyngeal Cancer Therapeutics Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Pharyngeal Cancer Therapeutics Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Pharyngeal Cancer Therapeutics Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Pharyngeal Cancer Therapeutics Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Pharyngeal Cancer Therapeutics Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Pharyngeal Cancer Therapeutics Revenue (Million USD) and Growth Rate (2014-2024)
Table AstraZeneca Plc Basic Information, Manufacturing Base and Competitors
Table AstraZeneca Plc Pharyngeal Cancer Therapeutics Type and Applications
Table AstraZeneca Plc Pharyngeal Cancer Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
Table Sanofi Basic Information, Manufacturing Base and Competitors
Table Sanofi Pharyngeal Cancer Therapeutics Type and Applications
Table Sanofi Pharyngeal Cancer Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
Table F. Hoffmann-La Roche Ltd. Basic Information, Manufacturing Base and Competitors
Table F. Hoffmann-La Roche Ltd. Pharyngeal Cancer Therapeutics Type and Applications
Table F. Hoffmann-La Roche Ltd. Pharyngeal Cancer Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
Table Bristol-Myers Squibb Co. Basic Information, Manufacturing Base and Competitors
Table Bristol-Myers Squibb Co. Pharyngeal Cancer Therapeutics Type and Applications
Table Bristol-Myers Squibb Co. Pharyngeal Cancer Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
Table Pfizer Inc. Basic Information, Manufacturing Base and Competitors
Table Pfizer Inc. Pharyngeal Cancer Therapeutics Type and Applications
Table Pfizer Inc. Pharyngeal Cancer Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
Table Eli Lilly and Co. Basic Information, Manufacturing Base and Competitors
Table Eli Lilly and Co. Pharyngeal Cancer Therapeutics Type and Applications
Table Eli Lilly and Co. Pharyngeal Cancer Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
Table Teva Pharmaceutical Industries Ltd. Basic Information, Manufacturing Base and Competitors
Table Teva Pharmaceutical Industries Ltd. Pharyngeal Cancer Therapeutics Type and Applications
Table Teva Pharmaceutical Industries Ltd. Pharyngeal Cancer Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
Table Mylan NV Basic Information, Manufacturing Base and Competitors
Table Mylan NV Pharyngeal Cancer Therapeutics Type and Applications
Table Mylan NV Pharyngeal Cancer Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
Table Merck & Co., Inc. Basic Information, Manufacturing Base and Competitors
Table Merck & Co., Inc. Pharyngeal Cancer Therapeutics Type and Applications
Table Merck & Co., Inc. Pharyngeal Cancer Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
Table Sun Pharmaceutical Industries Ltd. Basic Information, Manufacturing Base and Competitors
Table Sun Pharmaceutical Industries Ltd. Pharyngeal Cancer Therapeutics Type and Applications
Table Sun Pharmaceutical Industries Ltd. Pharyngeal Cancer Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
Table Global Pharyngeal Cancer Therapeutics Revenue (Million USD) by Players (2014-2019)
Table Global Pharyngeal Cancer Therapeutics Revenue Share by Players (2014-2019)
Figure Global Pharyngeal Cancer Therapeutics Revenue Share by Players in 2017
Figure Global Pharyngeal Cancer Therapeutics Revenue Share by Players in 2018
Figure Global Top 5 Players Pharyngeal Cancer Therapeutics Revenue Market Share in 2018
Figure Global Top 10 Players Pharyngeal Cancer Therapeutics Revenue Market Share in 2018
Figure Global Pharyngeal Cancer Therapeutics Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Pharyngeal Cancer Therapeutics Revenue (Million USD) by Regions (2014-2019)
Table Global Pharyngeal Cancer Therapeutics Revenue Market Share by Regions (2014-2019)
Figure Global Pharyngeal Cancer Therapeutics Revenue Market Share by Regions (2014-2019)
Figure Global Pharyngeal Cancer Therapeutics Revenue Market Share by Regions in 2018
Figure North America Pharyngeal Cancer Therapeutics Revenue and Growth Rate (2014-2019)
Figure Europe Pharyngeal Cancer Therapeutics Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Pharyngeal Cancer Therapeutics Revenue and Growth Rate (2014-2019)
Figure South America Pharyngeal Cancer Therapeutics Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Pharyngeal Cancer Therapeutics Revenue and Growth Rate (2014-2019)
Table North America Pharyngeal Cancer Therapeutics Revenue by Countries (2014-2019)
Table North America Pharyngeal Cancer Therapeutics Revenue Market Share by Countries (2014-2019)
Figure North America Pharyngeal Cancer Therapeutics Revenue Market Share by Countries (2014-2019)
Figure North America Pharyngeal Cancer Therapeutics Revenue Market Share by Countries in 2018
Figure USA Pharyngeal Cancer Therapeutics Revenue and Growth Rate (2014-2019)
Figure Canada Pharyngeal Cancer Therapeutics Revenue and Growth Rate (2014-2019)
Figure Mexico Pharyngeal Cancer Therapeutics Revenue and Growth Rate (2014-2019)
Table Europe Pharyngeal Cancer Therapeutics Revenue (Million USD) by Countries (2014-2019)
Figure Europe Pharyngeal Cancer Therapeutics Revenue Market Share by Countries (2014-2019)
Figure Europe Pharyngeal Cancer Therapeutics Revenue Market Share by Countries in 2018
Figure Germany Pharyngeal Cancer Therapeutics Revenue and Growth Rate (2014-2019)
Figure UK Pharyngeal Cancer Therapeutics Revenue and Growth Rate (2014-2019)
Figure France Pharyngeal Cancer Therapeutics Revenue and Growth Rate (2014-2019)
Figure Russia Pharyngeal Cancer Therapeutics Revenue and Growth Rate (2014-2019)
Figure Italy Pharyngeal Cancer Therapeutics Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Pharyngeal Cancer Therapeutics Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Pharyngeal Cancer Therapeutics Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Pharyngeal Cancer Therapeutics Revenue Market Share by Countries in 2018
Figure China Pharyngeal Cancer Therapeutics Revenue and Growth Rate (2014-2019)
Figure Japan Pharyngeal Cancer Therapeutics Revenue and Growth Rate (2014-2019)
Figure Korea Pharyngeal Cancer Therapeutics Revenue and Growth Rate (2014-2019)
Figure India Pharyngeal Cancer Therapeutics Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Pharyngeal Cancer Therapeutics Revenue and Growth Rate (2014-2019)
Table South America Pharyngeal Cancer Therapeutics Revenue by Countries (2014-2019)
Table South America Pharyngeal Cancer Therapeutics Revenue Market Share by Countries (2014-2019)
Figure South America Pharyngeal Cancer Therapeutics Revenue Market Share by Countries (2014-2019)
Figure South America Pharyngeal Cancer Therapeutics Revenue Market Share by Countries in 2018
Figure Brazil Pharyngeal Cancer Therapeutics Revenue and Growth Rate (2014-2019)
Figure Argentina Pharyngeal Cancer Therapeutics Revenue and Growth Rate (2014-2019)
Figure Colombia Pharyngeal Cancer Therapeutics Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Pharyngeal Cancer Therapeutics Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Pharyngeal Cancer Therapeutics Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Pharyngeal Cancer Therapeutics Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Pharyngeal Cancer Therapeutics Revenue Market Share by Countries in 2018
Figure Saudi Arabia Pharyngeal Cancer Therapeutics Revenue and Growth Rate (2014-2019)
Figure UAE Pharyngeal Cancer Therapeutics Revenue and Growth Rate (2014-2019)
Figure Egypt Pharyngeal Cancer Therapeutics Revenue and Growth Rate (2014-2019)
Figure Nigeria Pharyngeal Cancer Therapeutics Revenue and Growth Rate (2014-2019)
Figure South Africa Pharyngeal Cancer Therapeutics Revenue and Growth Rate (2014-2019)
Table Global Pharyngeal Cancer Therapeutics Revenue (Million USD) by Type (2014-2019)
Table Global Pharyngeal Cancer Therapeutics Revenue Share by Type (2014-2019)
Figure Global Pharyngeal Cancer Therapeutics Revenue Share by Type (2014-2019)
Figure Global Pharyngeal Cancer Therapeutics Revenue Share by Type in 2018
Table Global Pharyngeal Cancer Therapeutics Revenue Forecast by Type (2019-2024)
Figure Global Pharyngeal Cancer Therapeutics Market Share Forecast by Type (2019-2024)
Figure Global Targeted Therapy Revenue Growth Rate (2014-2019)
Figure Global Chemotherapy Revenue Growth Rate (2014-2019)
Table Global Pharyngeal Cancer Therapeutics Revenue by Application (2014-2019)
Table Global Pharyngeal Cancer Therapeutics Revenue Share by Application (2014-2019)
Figure Global Pharyngeal Cancer Therapeutics Revenue Share by Application (2014-2019)
Figure Global Pharyngeal Cancer Therapeutics Revenue Share by Application in 2018
Table Global Pharyngeal Cancer Therapeutics Revenue Forecast by Application (2019-2024)
Figure Global Pharyngeal Cancer Therapeutics Market Share Forecast by Application (2019-2024)
Figure Global Hospital Revenue Growth Rate (2014-2019)
Figure Global Clinic Revenue Growth Rate (2014-2019)
Figure Global Other Revenue Growth Rate (2014-2019)
Figure Global Pharyngeal Cancer Therapeutics Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Pharyngeal Cancer Therapeutics Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Pharyngeal Cancer Therapeutics Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Pharyngeal Cancer Therapeutics Revenue Market Forecast (2019-2024)
Figure Europe Pharyngeal Cancer Therapeutics Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Pharyngeal Cancer Therapeutics Revenue Market Forecast (2019-2024)
Figure South America Pharyngeal Cancer Therapeutics Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Pharyngeal Cancer Therapeutics Revenue Market Forecast (2019-2024)
Keyplayers in Global Pharyngeal Cancer Therapeutics Market 2019 by Company, Regions, Type and Application, Forecast to 2024
AstraZeneca PlcSanofi
F. Hoffmann-La Roche Ltd.
Bristol-Myers Squibb Co.
Pfizer Inc.
Eli Lilly and Co.
Teva Pharmaceutical Industries Ltd.
Mylan NV
Merck & Co., Inc.
Sun Pharmaceutical Industries Ltd.
